BV could inhibit epithelial-mesenchymal transition (EMT), increase the expression of vimentin, down-regulate the E-cadherin expression, and inhibit the recombination of F-actin related to the tumor metastasis in lung cancer A549, H1739 and H23 cells induced by epidermal growth factor (EGF). This evidence concerns the gene EGF and lung carcinoma.